IP Library Granted Patent US 9,737,549
Granted Patent B2
US 9,737,549 · App. 14/091,109 · Granted Aug 22, 2017

Formulations of deoxycholic acid and salts thereof

Inventors: Robert Emil Hodge (McPherson, KS); Jeffrey Douglas Webster (Thousand Oaks, CA); Robert M. Moriarty (Michiana Shores, IN)
Assignee: Kythera Biopharmaceuticals, Inc.
A61K31/575A61K9/0019A61K47/02A61K47/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,737,549
App. No.
14/091,109
Granted
Aug 22, 2017
Kind
B2
Abstract

The present application is directed to an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid, wherein the composition is maintained at a pH from about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also disclosed herein, are methods for stabilizing an aqueous pharmaceutical composition comprising from about 0.4% w/v to less than about 2% w/v of a salt of deoxycholic acid against precipitation, said method comprising maintaining pH of the solution from about 8.1 to about 8.5.

Claims (9)

1. A method for stabilizing an aqueous composition of a salt of deoxycholic acid against precipitation during storage, which method comprises:

a) forming an aqueous solution of the salt of deoxycholic acid;

b) adjusting the pH of the aqueous solution to a pH of from about 8.1 to about 8.5 thereby stabilizing said composition against precipitation during storage; and

c) and forming the aqueous composition consisting of the salt of deoxycholic acid at a concentration ranging from about 0.4% w/v to less than 2% w/v and at least one pharmaceutically acceptable excipient and/or carrier.

2. The method of claim 1 , wherein said salt is the sodium salt of deoxycholic acid.

3. The method of claim 1 , wherein the pH of the aqueous solution is maintained at about 8.3.

4. The method of claim 3 , wherein said salt is the sodium salt of deoxycholic acid.

5. The method of claim 1 , wherein the pH is maintained at from about 8.1 to about 8.5.

6. The method of claim 5 , wherein the pH is maintained with a sufficient amount of buffer.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Nov 21, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 051082/0635 →
CHANGE OF NAME Recorded Oct 9, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 051798/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2015
From: HODGE, ROBERT EMIL; WEBSTER, JEFFREY DOUGLAS; MORIARTY, ROBERT M
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 035870/0528 →
Continuity (4)
Continuation 13207337 · Aug 10, 2011
Continuation In Part PCTUS2011031284 · Apr 5, 2011
Provisional Application 61483008 · May 5, 2011
Related Publication 20140148429A1 · May 29, 2014